La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

i-SENS Bilan de santé

Santé financière contrôle des critères 3/6

i-SENS possède un total de capitaux propres de ₩303.4B et une dette totale de ₩139.9B, ce qui porte son ratio d'endettement à 46.1%. Son actif total et son passif total sont ₩498.7B et de ₩195.4B. L'EBIT de i-SENS est ₩6.9B ce qui fait que son ratio de couverture des intérêts 4.3. Elle dispose de liquidités et de placements à court terme de ₩57.8B.

Informations clés

54.7%

Ratio d'endettement

₩172.47b

Dette

Ratio de couverture des intérêts	1.7x
Argent liquide	₩109.11b
Fonds propres	₩315.58b
Total du passif	₩239.66b
Total des actifs	₩555.24b

Mises à jour récentes de la santé financière

Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

Mar 16

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Dec 02

Recent updates

i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Aug 05

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

Jan 18

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Jan 05

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

Dec 24

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 15

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Dec 02

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Nov 20

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de A099190 ( ₩208.5B ) dépassent ses passifs à court terme ( ₩138.6B ).

Passif à long terme: Les actifs à court terme de A099190 ( ₩208.5B ) dépassent ses passifs à long terme ( ₩56.7B ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de A099190 ( 27.1% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de A099190 est passé de 20.5% à 46.1% au cours des 5 dernières années.

Couverture de la dette: La dette de A099190 n'est pas bien couverte par le flux de trésorerie opérationnel ( 14.3% ).

Couverture des intérêts: Les paiements d'intérêts de A099190 sur sa dette ne sont pas bien couverts par l'EBIT ( 1.7 x couverture).

i-SENS Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Recent updates

i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Kwang Dong Pharmaceutical Co., Ltd. (KOSE:A009290) agreed to acquire 29.7% stake in Precision Biosensor, Inc. (KOSDAQ:A335810) from i-SENS, Inc. (KOSDAQ:A099190) from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion.

First quarter 2024 earnings released: ₩10.00 loss per share (vs ₩153 profit in 1Q 2023)

i-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd

i-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd

i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Full year 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of ₩175 per share at 0.7% yield

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 40%

New major risk - Revenue and earnings growth

Price target increased by 25% to ₩27,500

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 17%

Price target decreased by 9.8% to ₩39,700

Upcoming dividend of ₩300 per share

Less than half of directors are independent

Consensus forecasts updated

Consensus EPS estimates fall by 10%

Price target increased to ₩40,500

Less than half of directors are independent

Upcoming dividend of ₩250 per share

Consensus forecasts updated

Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

Consensus forecasts updated

Investor sentiment improved over the past week

Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?

Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?

i-SENS, Inc., Annual General Meeting, Mar 26, 2021

New 90-day low: ₩25,050

Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?

How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

New 90-day low: ₩26,450

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

New 90-day high: ₩29,650

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Price target raised to ₩37,000

New 90-day high - ₩30,550

New 90-day high - ₩29,500

Price target lowered to ₩33,000

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines